Investigation of Efficacy Enhancing and Toxicity Reducing Mechanism of Combination of Aconiti Lateralis Radix Praeparata and Paeoniae Radix Alba in Adjuvant-Induced Arthritis Rats by Metabolomics

• Published in: Evidence-based complementary and alternative medicine 2019-01, Vol.2019 (2019), p.1-15
• Main Authors: Peng, Cheng, Gong, Xiao-hong, Yu, Lei, Xie, Jun, Liu, Meichen, Feng, Wu-wen, Xie, Yun-fei, Li, Yunxia
• Format: Article
• Language: English
• Subjects: Adenosine; Adjuvants; Alkaloids; Amino acids; Arginine; Arthritis; Bile acids; Biomarkers; Carnitine; Catechol; Chinese medicine; Citric acid; Data processing; Deoxycholic acid; Dexamethasone; Ethylenediaminetetraacetic acid; Evidence-based medicine; Glucosides; Health aspects; Information management; Investigations; Leucine; Lysine; Metabolic disorders; Metabolites; Metabolomics; Pharmaceuticals; Phenylalanine; Rheumatoid arthritis; Rheumatoid factor; Spermidine; Toxicity; Tryptophan; γ-Interferon
• ISSN: 1741-427X; 1741-4288
• DOI: 10.1155/2019/9864841

Combination of Aconiti Lateralis Radix Praeparata (FZ) and Paeoniae Radix Alba (BS) shows a significant effect in rheumatoid arthritis (RA). This study aimed to investigate the efficacy enhancing and toxicity reducing mechanism of combination of them in adjuvant-induced arthritis (AIA) rats by metabolomics. Rats were randomly divided into seven groups, including A (healthy control), B (model control), C1 (therapy group), C2 (efficacy enhancing group), D1 (toxicity group), and D2 (toxicity reducing group), and dexamethasone group was used as positive control. The plasma biochemical indexes showed that therapeutic dose of lipid-soluble alkaloids of FZ could significantly inhibit the concentrations of IL-1β, TNF-α, and IFN-γ in AIA rats, and combination with total glucosides of peony could further reduce the concentration of IL-1β. Then, UPLC-LTQ/Orbitrap MS with untargeted metabolomics was performed to identify the possible metabolites and pathways. Through multivariate data analysis of therapeutic dose groups (A vs. B vs. C1 vs. C2) and multivariate data analysis of toxic dose groups (A vs. B vs. D1 vs. D2), 10 and 7 biomarkers were identified based on biomarker analysis, respectively. After inducing AIA model, the plasma contents of spermidine, vanillylmandelic acid, catechol, and linoleate were increased significantly, and the contents of citric acid, L-tyrosine, L-phenylalanine, leucine, L-tryptophan, and uridine 5'-monophosphate (UMP) were decreased significantly. High dose of lipid-soluble alkaloids of FZ could increase the plasma contents of L-lysine, L-arginine, and deoxycholic acid, while the plasma contents of UMP, carnitine, N-formylanthranilic acid, and adenosine were decreased significantly. The pathway analysis indicated that therapeutic dose of lipid-soluble alkaloids of FZ could regulate energy and amino acid metabolic disorders in AIA rats. However, toxic dose could cause bile acid, fat, amino acid, and energy metabolic disorders. And combination with total glucosides of peony could enhance the therapeutic effects and attenuate the toxicity induced by lipid-soluble alkaloids of FZ.